![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 33, 34530-34536, August 13, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the
Department of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, Colorado 80309 and ¶Department of Pathology, University of Washington, Seattle, Washington 98195
Tumor necrosis factor (TNF) has multiple biological effects such as participating in inflammation, apoptosis, and cell proliferation, but the mechanisms of its effects on epithelial cell proliferation have not been examined in detail. At the early stages of liver regeneration, TNF functions as a priming agent for hepatocyte replication and increases the sensitivity of hepatocytes to growth factors such as transforming growth factor
(TGF
); however, the mechanisms by which TNF interacts with growth factors and enhances hepatocyte replication are not known. Using the AML-12 hepatocyte cell line, we show that TNF stimulates proliferation of these cells through transactivation of the epidermal growth factor receptor (EGFR). The transactivation mechanism involves the release of TGF
into the medium through activation of the metalloproteinase TNF
-converting enzyme (also known as ADAM 17). Binding of the ligand to EGFR initiates a mitogenic cascade through extracellular signal-regulated kinases 1 and 2 and the partial involvement of protein kinase B. TNF-induced release of TGF
and activation of EGFR signaling were inhibited by TNF
protease inhibitor-1, an agent that interferes with TNF
-converting enzyme activity. We suggest that TNF-induced transactivation of EGFR may provide an early signal for the entry of hepatocytes into the cell cycle and may integrate proliferative and survival pathways at the start of liver regeneration.
Received for publication, May 21, 2004 , and in revised form, June 14, 2004.
* This work was supported in part by National Institutes of Health Grant CA-23226. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by National Institutes of Health Grant T32-ES07032-23.
|| To whom correspondence should be addressed: Dept. of Pathology, University of Washington, Box 357470, Seattle, WA 98195. Tel.: 206-616-4550; Fax: 206-616-1943; E-mail: nfausto{at}u.washington.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Yamaoka, F. Yan, H. Cao, S. S. Hobbs, R. S. Dise, W. Tong, and D. B. Polk Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis PNAS, August 19, 2008; 105(33): 11772 - 11777. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Riehle, J. S. Campbell, R. S. McMahan, M. M. Johnson, R. P. Beyer, T. K. Bammler, and N. Fausto Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3 J. Exp. Med., January 21, 2008; 205(1): 91 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S.Y. Cheung, J. T. Brooling, M. M. Johnson, K. J. Riehle, J. S. Campbell, and N. Fausto Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells Carcinogenesis, December 1, 2007; 28(12): 2624 - 2631. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Natarajan, B. Wagner, and M. Sibilia The EGF receptor is required for efficient liver regeneration PNAS, October 23, 2007; 104(43): 17081 - 17086. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Stoick-Cooper, R. T. Moon, and G. Weidinger Advances in signaling in vertebrate regeneration as a prelude to regenerative medicine Genes & Dev., June 1, 2007; 21(11): 1292 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Osawa, P. D. Yim, D. Xu, R. A. Panettieri, and C. W. Emala Raf-1 kinase mediates adenylyl cyclase sensitization by TNF-{alpha} in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1414 - L1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Singhirunnusorn, Y. Ueno, M. Matsuo, S. Suzuki, I. Saiki, and H. Sakurai Transient Suppression of Ligand-mediated Activation of Epidermal Growth Factor Receptor by Tumor Necrosis Factor-{alpha} through the TAK1-p38 Signaling Pathway J. Biol. Chem., April 27, 2007; 282(17): 12698 - 12706. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Finzi, V. Barbu, P.-R. Burgel, M. Mergey, K. S. Kirkwood, E. C. Wick, J.-Y. Scoazec, F. Peschaud, F. Paye, J. A. Nadel, et al. MUC5AC, a Gel-Forming Mucin Accumulating in Gallstone Disease, Is Overproduced via an Epidermal Growth Factor Receptor Pathway in the Human Gallbladder Am. J. Pathol., December 1, 2006; 169(6): 2031 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Campbell, K. J. Riehle, J. T. Brooling, R. L. Bauer, C. Mitchell, and N. Fausto Proinflammatory Cytokine Production in Liver Regeneration Is Myd88-Dependent, but Independent of Cd14, Tlr2, and Tlr4 J. Immunol., February 15, 2006; 176(4): 2522 - 2528. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ando, T. Ohmori, F. Inoue, T. Kadofuku, T. Hosaka, H. Ishida, T. Shirai, K. Okuda, T. Hirose, N. Horichi, et al. Enhancement of Sensitivity to Tumor Necrosis Factor {alpha} in Non-Small Cell Lung Cancer Cells with Acquired Resistance to Gefitinib Clin. Cancer Res., December 15, 2005; 11(24): 8872 - 8879. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Montesano, P. Soulie, J. A. Eble, and F. Carrozzino Tumour necrosis factor {alpha} confers an invasive, transformed phenotype on mammary epithelial cells J. Cell Sci., August 1, 2005; 118(15): 3487 - 3500. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Stuelten, S. D. Byfield, P. R. Arany, T. S. Karpova, W. G. Stetler-Stevenson, and A. B. Roberts Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-{alpha} and TGF-{beta} J. Cell Sci., May 15, 2005; 118(10): 2143 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Monick, K. Cameron, J. Staber, L. S. Powers, T. O. Yarovinsky, J. G. Koland, and G. W. Hunninghake Activation of the Epidermal Growth Factor Receptor by Respiratory Syncytial Virus Results in Increased Inflammation and Delayed Apoptosis J. Biol. Chem., January 21, 2005; 280(3): 2147 - 2158. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |